Records containing: Stage IB Pancreatic Cancer
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-05-02Generation of Patient Derived Pancreatic Cancer Cell Lines to Determine Mechanisms of Chemoresistance
-
CLINICAL_TRIALS study record update · 2024-03-20Phase I Integrated Biomarker Trial of VX15/2503 in Combination With Ipilimumab or Nivolumab in Patients With Pancreatic and Colorectal Cancer
-
CLINICAL_TRIALS study record update · 2022-09-19A Phase 1 Study of Neoadjuvant Chemotherapy, Followed by Concurrent Chemoradiation With Gemcitabine, Sorafenib, and Vorinostat in Pancreatic Cancer
-
CLINICAL_TRIALS study record update · 2022-06-01A Phase Ia-Ib Dose-escalation Study Evaluating Safety and Efficacy of Neoadjuvant Stereotactic Body Radiotherapy (SBRT) With Concomitant Capecitabine Chemotherapy for Resectable Carcinoma of Exocrine Pancreas.
-
CLINICAL_TRIALS study record update · 2021-01-07Electronic Monitoring of Patient-Reported Outcomes and Function in GI Cancer Surgery: A Feasibility Study
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2019-11-15A Phase II Study of Neoadjuvant Chemotherapy With and Without Immunotherapy to CA125 (Oregovomab) Followed by Hypofractionated Stereotactic Radiotherapy & Concurrent HIV Protease Inhibitor Nelfinavir in Locally Advanced Pancreatic Cancer
-
CLINICAL_TRIALS study record update · 2018-07-13Preoperative Folfirinox for Resectable Pancreatic Adenocarcinoma - A Phase II Study
-
CLINICAL_TRIALS study record update · 2018-01-09A Multicenter, Open-Label, Randomized, Phase II Trial of Adjuvant Dasatinib Plus Gemcitabine Versus Single-Agent Gemcitabine in Patients With Resected Pancreatic Adenocarcinoma
-
CLINICAL_TRIALS study record update · 2017-07-13A Phase II Study Induction Chemotherapy, Neoadjuvant Chemoradiotherapy, Surgical Resection and Adjuvant Chemotherapy for Patients With Locally Advanced, Resectable Pancreatic Adenocarcinoma
-
CLINICAL_TRIALS study record update · 2015-07-15A Pharmacodynamic Study of Metformin in Patients With Resectable Pancreatic Cancer
-
CLINICAL_TRIALS study record update · 2014-05-19Phase IIA Trial Testing Erlotinib as an Intervention Against Intraductal Pancreatic Mucinous Neoplasms
-
CLINICAL_TRIALS study record update · 2013-11-25An Intergroup Randomized Phase II Study of Bevacizumab (NSC 704865) or Cetuximab (NSC 714692) in Combination With Gemcitabine and in Combination With Chemoradiation (Capecitabine and Radiation) in Patients With Completely-Resected Pancreatic Carcinoma
-
CLINICAL_TRIALS study record update · 2013-09-30A Neoadjuvant Pharmacodynamic Study Of RO4929097 (RO) in Pancreas Cancer